Advertisement
News
Subscribe to MDT Magazine News

BU robotics research aims to straighten gaits

October 26, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | Comments

A Boston University professor has developed a robotics device designed to help prevent hip damage created by an incorrect gait. The goal is to correct a healthy patient’s walking gait early on so osteoarthritis doesn’t develop later in life.

MDS changing name to Nordion Inc. on Nov. 1; new TSX ticker symbol will be NDN

October 26, 2010 9:45 am | by The Associated Press | Comments

Medical imaging company MDS Inc. (TSX:MDS) (NYSE:MDZ)announced Tuesday it will make its long-awaited name change to Nordion Inc. on Nov. 1.Along with the new name, the company will also change its stock ticker symbols to NDN on the Toronto Stock Exchange and NDZ on the big board in New York.The...

Reportlinker Adds Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

October 26, 2010 9:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Oct. 26 /- Reportlinker.com announces that a new market research report is available in its catalogue: Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others...

TOPICS:
Advertisement

BU research aims to straighten gaits

October 26, 2010 9:34 am | by Mass High Tech: The Journal of New England Technology | Comments

A Boston University professor has developed a robotics device designed to help prevent hip damage created by an incorrect gait. The goal is to correct a healthy patient’s walking gait early on so osteoarthritis doesn’t develop later in life.

TOPICS:

Installation of Next Generation Proton Therapy System Progressing Rapidly

October 26, 2010 9:34 am | by Bio-Medicine.Org | Comments

LITTLETON, Mass., Oct. 26 /- Still River Systems' groundbreaking proton therapy system is entering the final phase of installation at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO, a National Cancer Institute (NCI)...

TOPICS:

Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study

October 26, 2010 9:33 am | by Bio-Medicine.Org | Comments

HAMILTON, N.J. and ROCKVILLE, Md., Oct. 26 /- MedAvante, Inc., the leader in centralized expert evaluation of central nervous system (CNS) disorders, and Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN ) a clinical stage pharmaceutical company developing and commercializing potential best in...

TOPICS:

Siemens Wins $25 Million Contract From Rush University Medical Center

October 26, 2010 9:33 am | by Bio-Medicine.Org | Comments

MALVERN, Pa., Oct. 26 /- Rush University Medical Center in Chicago, one of the top academic medical centers in the United States, has awarded a five-year, $25 million contract for medical equipment and health IT consulting services to Siemens Medical Solutions USA, Inc. With the addition...

TOPICS:

Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention

October 26, 2010 9:32 am | by Bio-Medicine.Org | Comments

BETHLEHEM, Pa., Oct. 26 /- A landmark study of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices offer significantly better protection against accidental needlestick injuries (NSIs) than early...

TOPICS:
Advertisement

Gentiva® Health Services to Present at the Oppenheimer and Credit Suisse Healthcare Conferences

October 26, 2010 7:35 am | by Bio-Medicine.Org | Comments

ATLANTA, Oct. 26 /-Gentiva Health Services, Inc. (Nasdaq: GTIV ), the nation's largest provider of home health and hospice services, announced today that it will present at the Oppenheimer 21st Annual Healthcare Conference in New York at 2:10 p.m. ET on Tuesday, November 2, 2010 and the...

TOPICS:

ARIAD reports positive test results, plans stock offering

October 26, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | Comments

ARIAD Pharmaceuticals Inc. has announced a stock offering to help fund tests on a treatment for chronic myeloid leukemia, while also reporting that a Phase 2 study of its treatment for endometrial cancer showed significant improvements in progression-free survival.

Intermittent Catheter Market Currently Valued at $230 Million and Set to Double by 2014

October 26, 2010 6:34 am | by Bio-Medicine.Org | Comments

TORONTO, Oct. 26 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, reimbursement changes have caused the demand for intermittent catheters to increase significantly. In April 2008, Medicare changed reimbursement to cover up to...

TOPICS:

Next Intelligence Health Expands US Channel Program

October 26, 2010 6:34 am | by Bio-Medicine.Org | Comments

WILMINGTON, Del., Oct. 26 /- Next Intelligence Corporation ( www.niq-health.com ), the leader in message-based nurse call systems, today announced the expansion of its channel program for CarePlus™ and invites IT resellers, value added resellers (VAR) and system integrators (SI) to...

TOPICS:

Accuray Incorporated to Speak at Oppenheimer's 21st Annual Healthcare Conference

October 26, 2010 6:33 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Oct. 26 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the Oppenheimer Healthcare Conference in New York City on Wednesday, November 3, 2010 at 9:40 a.m. ET/6:40 a.m....

TOPICS:

Frost & Sullivan Award Highlights Hybridyne Technologies' Outstanding Technology Innovation

October 26, 2010 6:32 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Oct. 26 /- Based on its recent analysis of the prostate cancer diagnosis market, Frost & Sullivan recognizes Hybridyne Technologies, Inc. with the 2010 North American Frost & Sullivan Award for Technology Innovation of the Year. (Logo:  ...

TOPICS:

Amedisys 3Q profit tumbles 40 percent

October 26, 2010 5:45 am | by The Associated Press | Comments

Amedisys Inc. said its third-quarter net income fell 40 percent, as the home health provider continued to see a volume fall-off that started in the second quarter, and it lowered the upper end of its profit forecast for 2010.The Baton Rouge, La., company said it earned $21.6 million, or 76...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading